PEAK6
LH icon

PEAK6’s Labcorp LH Stock Holding History

PEAK6’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,600
Closed -$1.32M – 3135
2025
Q3 		$1.32M Hold
4,600
– – ﹤0.01% 1721
2025
Q2 		$1.21M Buy
+4,600
New +$1.12M ﹤0.01% 1710

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PEAK6's LH Position: Q4 2025 in Review

PEAK6 sold out of Labcorp (LH) in Q4 2025, closing a stake of 2 shares — an estimated $531 sold.

PEAK6 first reported a position in LH in Q2 2025 and held it in 2 quarters. The position peaked at $756 in Q2 2025. 1,024 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • PEAK6 reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • PEAK6 sold 2 Labcorp shares in Q4 2025, an estimated $531.
  • PEAK6 first reported a position in Labcorp in Q2 2025 and held it in 2 quarters.
  • PEAK6's Labcorp position peaked at $756 in Q2 2025.
  • 1,024 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on PEAK6's 13F filing for Q4 2025, filed 13 Feb 2026.